Juvenile Nasopharyngeal Angiofibroma (JNA) is a rare, benign, and highly vascular and locally aggressive tumor that accounts for 0.05% to 0.5% of all head and neck neoplasms generally seen in prepubertal and mainly targeted to male adolescence [1-6]. The tumor originates from the superior edge of the sphenopalatine foramen and advances submucosally, through natural ostia, along canals and nerves and by bone erosion to the infratemporal fossa, pterygoid canal, parasellar region, sphenoid basis and the orbit [1,[4][5][6]. Facial deformity, reduced vision, exopthalmos and opthalmoplegia may develop. Therefore, despite its benign nature, JNA should be treated as radically as possible to prevent recurrence which is reported to be between 23 and 27.5% [1,5]. Several staging classification has been proposed, however Radkowski classification has been widely used for its practicality (Table 1) [3][4][5]7].